维普中文期刊产品整合服务
23篇 您的检索式:作者名="VINAI F"
    题名 作者 年代 出处 被引量
1High-frequency magne-tiompedance relaxation in melt-spun Co-based ribbons显示文摘Coisson M Tiberto P Vinai F 2002Journal of Magnetism and Magnetic Materials2002,,4:1
2Development of postureand locomotion:an interplay of endogenously genevated activi-ties and neurotrophic action by descending pathways显示文摘Vinay L Brocard F Clarac F 2002BrainRes Rev2002,40,13:1
3Development of posture and locomotion:an interplay of endogenously generated activities and neurotrophic actions by descending pathways显示文摘Vinay L Brocard F Clarac F 2002Brain Res Rev2002,40,13:1
4Major changes in the 2005 AHA Guideline for CPR and ECC reaching the tipping point for changel显示文摘Mary F Vinay M Robert W 2005Circulation2005,112,4:1
5Giant magnetoresitance in magnetic granular Co15Cu85 alloys annealed by direct-current Joule heating显示文摘YU R H ZHANG X X TEJADA T J KNOBEL M TIBERTO P ALLIA P VINAI F 1996Journal of Magnetism and Magnetic Materials1996,164,:1
6Major changes in the 2005 AHA Guidelines for CPR and ECC reaching the tipping point for change 显示文摘Mary F Vinay M Robert W 2005Circulation2005,112,4:1
7Major changes in the 2005 AHA Guideline for CPR and ECG reaching the tipping point for change显示文摘Mary F Vinay M Rohert W 2005Circulation2005,112,4:1
8Numerical simulation of non-i- sothermal viscoplastic waxy crude oil flows显示文摘Vinay G Wachs A Agassant J F 2005Journal of Non- Newtonian Fluid Mechanics2005,128,:1
9Nocturnal eating is part of the clinical spectrum of restless legs syndrome and an underestimated risk factor for increased body mass index 显示文摘Antelmi E Vinai P Pizza F 2014Sleep Med2014,15,2:1
10Major changes in the2005 AHA Guidelines for CPR and ECC reaching the tipping point for change显示文摘Mary F Vinay M Robert W 2005Circulation2005,112,4:1
11Simple approach to prenatal diagnosis of the great arteries显示文摘Vinais F Ascenzo R Poblete P 2006Ultrasound Obstet Gynecol2006,28,:1
12Major changes in the 2005 AHA Guidelines for CPR and ECC reaching the tipping point for change 显示文摘Mary F Vinay M Robert W 2005Circulation2005,112,4:1
13Major changes in the 2005 AHA Guideline for CPR and ECC reaching the tipping point forchange显示文摘MARY F VINAY M ROBERT W 2005Circulation2005,112,:1
14Major changes in the 2005 AHA Guidelines for CPR and ECC reaching the tipping point for change 显示文摘Mary F Vinay M Robert W 2005Circulation2005,112,4:1
15Meplazumab in hospitalized adults with severe COVID-19(DEFLECT):a multicenter,seamless phase 2/3,randomized,third-party double-blind clinical trial显示文摘Meplazumab,a humanized CD147 antibody,has shown favourable safety and efficacy in our previous clinical studies.In DEFLECT(NCT04586153),167 patients with severe COVID-19 were enroled and randomized to receive three dosages of meplazumab and a placebo.Meplazumab at 0.12 mg/kg,compared to the placebo group,showed clinical benefits in significantly reducing mortality by 83.6%(2.4%vs.14.6%,p=0.0150),increasing the proportion of patients alive and discharged without supplemental oxygen(82.9%vs.70.7%,p=0.0337)and increasing the proportion of patients who achieved sustained clinical improvement(41.5%vs.31.7%).The response rate in the 0.2 mg/kg group was relatively increased by 16.0%compared with the placebo group(53.7%vs.46.3%).Meplazumab also reduced the viral loads and multiple cytokine levels.Compare with the placebo group,the 0.3 mg/kg significantly increased the virus negative rate by 40.6%(p=0.0363)and reduced IL-8 level(p=0.0460);the 0.2 mg/kg increased the negative conversion rate by 36.9%,and reduced IL-4(p=0.0365)and IL-8 levels(p=0.0484).In this study,the adverse events occurred at a comparable rate across the four groups,with no unexpected safety findings observed.In conclusion,meplazumab promoted COVID-19 convalescence and reduced mortality,viral load,and cytokine levels in severe COVID-19 population with good safety profile.Huijie Bian Liang Chen Zhao-Hui Zheng Xiu-Xuan Sun Jie-Jie Geng Ruo Chen Ke Wang Xu Yang Shi-Rui Chen Si-Yu Chen Rong-Hua Xie Kui Zhang Jin-Lin Miao Jun-Feng Jia Hao Tang Shuang-Shuang Liu Hong-Wei Shi Yong Yang Xiao-Chun Chen Vinay Malhotra Nosheen Nasir Iffat Khanum Faisal Mahmood Saeed Hamid Claudio Marcel Berdun Stadnik Kengi Itinose Caroline Cândida Carvalho de Oliveira Cesar Dusilek Lucas Rivabem Adilson Joaquim Westheimer Cavalcante Suzara Souto Lopes Wladmir Faustino Saporito Fábio JoséConcilio Fucci Jesus Abraham Simon-Campos Ling Wang Lin-Na Liu Qing-Yi Wang Ding Wei Zheng Zhang Zhi-Nan Chen Ping Zhu 2023Signal Transduction and Targeted Therapy2023,8,2:1
16Opioids confer myocardial tolerance to ischemia: interaction of delta opioid agonists and antagonists 显示文摘Bolling S F Vinay B Charles F S 2001J Thorac Cardiovasc Surg2001,122,3:1
17Development of posture and locomotion:an interplay of endogenously generated activities and neurotrophic actions by descending pathways显示文摘Vinay L Brocarl F Clarac F 0,,1:1
18Major changes in the 2005 AHA Guidelines for CPR and ECC reaching the tipping point for change显示文摘Mary F Vinay M Robert W 2005Circulation2005,112,4:1
19Serotonergic modulation of post - synaptic inhibition and locomotor alternating pattern in the spinal cord显示文摘Gackiere F and Vinay L 2014Front Neural Circuits2014,8,:1
20Numerical simulation of weakly compressible Bingham flows= the restart of pipeline flows of waxy crude oils 显示文摘Vinay G Wachs A Agassant J F 2006Non-Newtonian Fluid Mech2006,136,:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费